Zobrazeno 1 - 10
of 572
pro vyhledávání: '"K, Shobha"'
Publikováno v:
In Journal of Ayurveda and Integrative Medicine July-September 2021 12(3):427-434
Autor:
Senthilkumar, Sivapriya a, Venugopal, Chaitra a, Parveen, Shagufta a, K, Shobha a, Rai, Kiranmai S. b, Kutty, Bindu M. c, Dhanushkodi, Anandh a, *
Publikováno v:
In Neurotoxicology December 2020 81:89-100
Publikováno v:
Indian Journal of Surgical Oncology. 13:702-706
Autor:
K. Shobha
Publikováno v:
Recent Trends in Computational Intelligence and Its Application ISBN: 9781003388913
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::204a07a666e80673e929f3e45e913caf
https://doi.org/10.1201/9781003388913-25
https://doi.org/10.1201/9781003388913-25
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Indian Journal of Gynecologic Oncology. 20
Publikováno v:
Trophoblastic diseases.
Autor:
H G Rangaraju, Y K Shobha
Publikováno v:
WSEAS TRANSACTIONS ON SYSTEMS AND CONTROL. 16:315-327
The hypothetically convenient structure is the Multiple-Input Multiple-Output Orthogonal Frequency Division Multiplexing (MIMO-OFDM) technique that is employed for upcoming generations in wireless communication systems. Some of the benefits offered b
Autor:
Rajashekar Kundargi, Praveen S. Rathod, T Rajatharangani, U. D. Bafna, V R Pallavi, Shruthi Shivdas, K Shobha, C R Vijay
Publikováno v:
Indian J Surg Oncol
The objectives of this study are to assess the role of non-chemotherapeutic combination of drugs as maintenance therapy, after standard treatment, for advanced epithelial ovarian cancers (EOC) and to determine the recurrence-free survival (RFS) and c
Autor:
Purushotham Chavan, C. Ramachandra, R. Krishnappa, K.S. Sabitha, Rathan Shetty, KT Siddappa, Ravi Arjunan, K Shobha, Pavan Sugoor, V R Pallavi, Syed Altaf, Rajshekar Halkud, Praveen S. Rathod, Uday Karjol
Publikováno v:
Indian Journal of Surgical Oncology
The COVID-19 pandemic has placed unprecedented pressure on healthcare services. Deprioritisation of nonemergency clinical services and growing concerns of adverse outcomes of COVID-19 in cancer patients is having a deleterious impact across oncologic